Aptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
18 Ottobre 2022 - 1:45PM
Business Wire
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical
company developing transformative therapies for the treatment of
brain and nervous system disorders, today announced that the
company will host a conference call and live webcast on Tuesday,
November 8, 2022 at 5:00 p.m. ET to report third quarter 2022
financial results and discuss recent business highlights.
To access the live conference call, please dial 844-200-6205
(domestic) or 929-526-1599 (international) and refer to conference
ID 141144. A live audio webcast of the event will be available on
the Investors & Media section of Aptinyx’s website at
https://ir.aptinyx.com. A replay of the webcast will be archived on
Aptinyx’s website for 30 days following the event.
About Aptinyx
Aptinyx Inc. is a clinical-stage biopharmaceutical company
focused on the discovery, development, and commercialization of
proprietary synthetic small molecules for the treatment of brain
and nervous system disorders. Aptinyx has a platform for discovery
of novel compounds that work through a unique mechanism to
modulate—rather than block or over-activate—NMDA receptors and
enhance synaptic plasticity, the foundation of neural cell
communication. The company has two product candidates in clinical
development in central nervous system indications, including
cognitive impairment and post-traumatic stress disorder. Aptinyx is
also advancing additional compounds from its proprietary discovery
platform, which continues to generate a rich and diverse pipeline
of small-molecule NMDA receptor modulators with the potential to
treat an array of neurologic disorders. For more information, visit
www.aptinyx.com.
Source: Aptinyx Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221018005503/en/
Investor & Media Contact: Patrick Flavin Aptinyx Inc.
ir@aptinyx.com or corporate@aptinyx.com 847-871-0377
Grafico Azioni Aptinyx (NASDAQ:APTX)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Aptinyx (NASDAQ:APTX)
Storico
Da Mag 2023 a Mag 2024